Document is current
Any future updates will be listed below
-
Authors
Parada, Humberto Jr http://orcid.org/0000-0001-6562-8577
Sun, Xuezheng
Fleming, Jodie M.
Williams-DeVane, ClarLynda R.
Kirk, Erin L.
Olsson, Linnea T.
Perou, Charles M.
Olshan, Andrew F.
Troester, Melissa A.
-
Funding
Funding for this research was provided by:
National Institutes of Health (U01 CA179715)
National Institutes of Health (U54 CA156733)
National Cancer Institute (P50 CA058223)
National Cancer Institute (P01 CA151135)
National Institute of Environmental Health Sciences (T32 ES007018)
- License Information
-
More Information
Article History
Received: 16 August 2017
Accepted: 7 November 2017
First Online: 11 December 2017
Ethics approval and consent to participate
: This study was approved by the Institutional Review Board of the University of North Carolina (UNC, Chapel Hill, NC). All participants gave informed consent before they entered the study.
: Not applicable.
: CMP is an equity stock holder, and Board of Director Member, of BioClassifier LLC and GeneCentric Diagnostics. CMP is also listed as an inventor on a patent application for the PAM50 assay. All other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
